Transdermal Drug Delivery System Market Growth Analysis, Trends Forecast by Regions and Types to 2024

Posted on 2021-07-28 by researchinsights in Healthcare // 0 Comments

San Jose, California , USA, July 28, 2021 — /EPR Network/ —

Global Transdermal Drug Delivery System Market is anticipated to reach USD 81.4 billion by 2024 owing to shift toward sedentary lifestyle that encourages chronic disorders. Transdermal drug delivery is a painless process of delivering drug in the body part. TDDS delivers drug through the skin in pre-decided and regulated rate. It offers extended therapeutic effects, lesser side-effects, improved patient compliance, better bioavailability, and easy cessation of drug treatment. Transdermal drug delivery is much preferred today as compared to the conventional oral method or injectables.

Transdermal drug delivery systems market is witnessing growth due to the factors like increasing consumer preference for minimally invasive procedures for chronic disorders and multiple advantages associated with TDDS. Infusion of drug could be effectively monitored and projected creditably through transdermal drug delivery method, which makes it convenient to maintain steady level of drug. However, transdermal drug delivery system industry is restrained by constrained areas of delivery and slow infusion rate hydrophilic drugs.

Request a Sample Copy of Transdermal Drug Delivery System Market Report @ https://www.millioninsights.com/industry-reports/transdermal-drug-delivery-system-market/request-sample

Recent years has introduced multiple drugs that could be delivered through transdermal route. Also, the existing market players in this market are focusing on mergers and acquisition to create niche market. Transdermal drug delivery system market is categorized on the basis of delivery system type, application, and geography.

Global Transdermal Drug Delivery Systems Product Outlook (Revenue, USD Billion, 2013 – 2024)

Electroporation
Radiofrequency
Iontophoresis
Microporation
Thermal
Mechanical arrays
Ultrasound
Others

Global Transdermal Drug Delivery Systems Application Outlook (Revenue, USD Billion, 2013 – 2024)

Central nervous system
Pain management
Cardiovascular
Hormone
Others

The prominent players in transdermal drug delivery systems industry include Acrux Limited, Echo Therapeutics, Inc., Johnson & Johnson, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Mylan N.V., Bayer AG, Endo Pharmaceuticals Inc. and Novartis AG.

Access Transdermal Drug Delivery System Market Report with TOC @ https://www.millioninsights.com/industry-reports/transdermal-drug-delivery-system-market

Transdermal Drug Delivery Systems Regional Outlook (Revenue, USD Billion, 2013 – 2024)

North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
Japan
China
India
Latin America
Mexico
Brazil
MEA
South Africa

Visit Our Blog: https://marketreportsassistance.wordpress.com

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Matched content

Editor’s pick